News NICE proposals could cut wait for specialist treatments and ... Technologies for very rare conditions will also be automatically funded.
Views & Analysis Digital health round-up: a new dawn in diabetes care, and mo... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Urgent need for clarity as government suspends pharmacy cut ... But reprieve may last only until plans have been reviewed.
News Owlstone's breath-based lung cancer diagnostic could save 10... Trial's next phase will recruit 3,000 patients across 21 international sites.
News Exercise prescription platform Physitrack selected for Londo... Web and app-based solution lets doctors prescribe post-operation recovery exercise programmes.
Views & Analysis A novel UK approach to cancer access: yes, no, or maybe? Experts discuss the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.